Health Affairs' Jeff Byers welcomes Katie Keith of Georgetown Law back to the pod to discuss President Trump's potential ...

The Centers for Medicare and Medicaid Services (CMS) proposed new limits on how states use provider taxes to finance their ...

The potential of biotech-powered consumer health is as sensitive as it is expansive. When it comes to consumer education, ...

For the many young adults living with diabetes, health insurance coverage transitions are not only stressful; they can also ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

By simulating various scenarios, predictive models help public health officials weigh the trade-offs between different ...

Now is the time for policy makers, payers, health systems, and clinicians to act decisively by extending AHCaH, evaluating ...

During the COVID-19 pandemic, suppression of scientific debate and the marginalization of dissenting voices weakened public ...

Massachusetts’ new health care reform expands the authority of the state to intervene prior to significant changes to the ...

As health scholars at the American Enterprise Institute, the Brookings Institution, and the Bipartisan Policy Center, we ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Caitlin Carroll of the University of Minnesota to discuss her recent ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...